Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets

Mostrar otras versiones (1)

Tremendous progress has been made to control the COVID‐19 pandemic caused by the SARS‐CoV‐2 virus. However, effective therapeutic options are still rare. Drug repurposing and combination represent practical strategies to address this urgent unmet medical need. Viruses, including coronaviruses, are k...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Kuoyuan, Martin‐Sancho, Laura, Pal, Lipika R, Pu, Yuan, Riva, Laura, Yin, Xin, Sinha, Sanju, Nair, Nishanth Ulhas, Chanda, Sumit K, Ruppin, Eytan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552660/
https://www.ncbi.nlm.nih.gov/pubmed/34709707
http://dx.doi.org/10.15252/msb.202110260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552660/
https://www.ncbi.nlm.nih.gov/pubmed/34709707
http://dx.doi.org/10.15252/msb.202110260

Ejemplares similares